Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, ...

Columnist Sam Kirton had to make some adjustments after his IPF diagnosis, but there are still plenty of ways to find joy, he says.

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

Rentosertib, an AI-generated small molecule targeting Traf2- and Nck-interacting kinase, was safe and improved FVC in ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

GRI Bio’s lead program, GRI-0621, is an inhibitor of iNKT cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis, a serious disease ...

G RI Bio has announced encouraging six-week interim safety outcomes from the ongoing Phase IIa trial of the small molecule ...

Insilico Medicine announces Nature Medicine publication of Phase IIa results evaluating rentosertib, the novel TNIK inhibitor for idiopathic pulmonary fibrosis (IPF) discovered and designed with a ...

Role of pirfenidone in the primary prophylaxis of lung cancer in idiopathic pulmonary fibrosis patients: A systematic review and meta-analysis.. If you have the appropriate software installed, you can ...

The trials were conducted with idiopathic pulmonary fibrosis patients or IPF (FIBRONEER-IPF study), and in secondary progressive pulmonary fibrosis (FIBRONEER-ILD study).

PureTech presented results of an open-label extension study of itsidiopathic pulmonary fibrosis candidate deupirfenidone, showing its durability.

About Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis (IPF) is a rare, progressive and fatal lung disease characterized by irreversible scarring of lung tissue.